Literature DB >> 6379947

Breakdown of the blood-retinal barriers and cystoid macular edema.

J G Cunha-Vaz, A Travassos.   

Abstract

After reviewing the definition, incidence and main etiologic factors of cystoid macular edema (CME) the authors analyze the structural and physiologic characteristics of the macular area, including the blood-retinal barriers, and the basic concepts of retinal edema. Personal observations on three different groups of diseases associated with CME, retinitis pigmentosa, pars planitis and aphakia, are presented. CME evaluation was made by slit-lamp microscopy, fluorescein angiography and vitreous fluorophotometry. In the situations examined, the main factors involved in CME formation appear to be a marked increase in blood-retinal-barrier barrier permeability and alterations in retinal tissue compliance.

Entities:  

Mesh:

Year:  1984        PMID: 6379947     DOI: 10.1016/0039-6257(84)90230-3

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  25 in total

Review 1.  The incidence, pathogenesis and treatment of cystoid macular edema following cataract surgery.

Authors:  A J Flach
Journal:  Trans Am Ophthalmol Soc       Date:  1998

2.  Relationship between perifoveal capillaries and pathomorphology in macular oedema associated with branch retinal vein occlusion.

Authors:  T Murakami; A Tsujikawa; K Miyamoto; A Sakamoto; M Ota; K Ogino; N Yoshimura
Journal:  Eye (Lond)       Date:  2012-06-01       Impact factor: 3.775

3.  Electroretinographic abnormalities in multiple sclerosis: possible role for retinal autoantibodies.

Authors:  Farzin Forooghian; Melanie Sproule; Carol Westall; Lynn Gordon; Guy Jirawuthiworavong; Kaori Shimazaki; Paul O'Connor
Journal:  Doc Ophthalmol       Date:  2006-09-14       Impact factor: 2.379

4.  Cystoid macular oedema in paediatric aphakia and pseudophakia.

Authors:  C Kirwan; M O'Keeffe
Journal:  Br J Ophthalmol       Date:  2006-01       Impact factor: 4.638

5.  The blood-ocular barriers: past, present, and future.

Authors:  J G Cunha-Vaz
Journal:  Doc Ophthalmol       Date:  1997       Impact factor: 2.379

6.  Maculopathy in patients with diabetes mellitus type 1 and type 2: associations with risk factors.

Authors:  E Zander; S Herfurth; B Bohl; P Heinke; U Herrmann; K D Kohnert; W Kerner
Journal:  Br J Ophthalmol       Date:  2000-08       Impact factor: 4.638

7.  Spectral sensitivity of the blood-retinal barrier at the pigment epithelium for blue light in the 400-500 nm range.

Authors:  B J Putting; J A van Best; R C Zweypfenning; G F Vrensen; J A Oosterhuis
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1993-10       Impact factor: 3.117

8.  Changes in morphology and visual function over time in mouse models of retinal degeneration: an SD-OCT, histology, and electroretinography study.

Authors:  Tomoko Hasegawa; Hanako O Ikeda; Noriko Nakano; Yuki Muraoka; Tatsuaki Tsuruyama; Keiko Okamoto-Furuta; Haruyasu Kohda; Nagahisa Yoshimura
Journal:  Jpn J Ophthalmol       Date:  2016-01-05       Impact factor: 2.447

9.  Topical indomethacin in the treatment of chronic cystoid macular edema.

Authors:  M Peterson; M O Yoshizumi; R Hepler; B Mondino; A Kreiger
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

10.  Functional implication of Dp71 in osmoregulation and vascular permeability of the retina.

Authors:  Abdoulaye Sene; Ramin Tadayoni; Thomas Pannicke; Antje Wurm; Brahim El Mathari; Romain Benard; Michel Joseph Roux; David Yaffe; Dominique Mornet; Andreas Reichenbach; Jose-Alain Sahel; Alvaro Rendon
Journal:  PLoS One       Date:  2009-10-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.